News
Article published in Drug Discovery Today: Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?
"A more high-level definition would be preferred while allowing further specification"
An article based on the discussions and findings from the RSNN Expert Meeting "Addressing the framework of unmet medical need", which took place earlier this year, was published recently in Drug Discovery Today. Our colleague Sophie Huiskes-Berends contributed to the article.
Lygature and RSNN
As a partner, Lygature provides the necessary managerial and scientific expertise to the RSNN, ensuring inclusive discussions and meaningful outputs. Activities include handling day-to-day operations of the RSNN, stakeholder management and scientific management.
Read the full article online here: link